首页 工具
登录
购物车

搜索结果

Search Results for " ralimetinib "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T16721 Ralimetinib

LY2228820

Others Others
Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor of p38 MAPK α/β (IC50s: 5.3 and 3.
T6047 Ralimetinib dimesylate

LY2228820 dimesylate,Ralimetinib,LY2228820,Ralimetinib Mesylate

Apoptosis; p38 MAPK; Autophagy Apoptosis; Autophagy; MAPK
Ralimetinib dimesylate (LY2228820 dimesylate) 是一种选择性,ATP 竞争性的 p38 MAPK α/β抑制剂,IC50分别为5.3 和 3.2 nM。

化合物

Ralimetinib
Cat.No: T16721
Synonym: LY2228820
Target: Others
Ralimetinib dimesylate
Cat.No: T6047
Synonym: LY2228820 dimesylate,Ralimetinib,LY2228820,Ralimetinib Mesylate
Target: Apoptosis, p38 MAPK, Autophagy
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼